10,123 reports of this reaction
5.0% of all TOPIRAMATE reports
#1 most reported adverse reaction
DRUG INEFFECTIVE is the #1 most commonly reported adverse reaction for TOPIRAMATE, manufactured by Janssen Pharmaceuticals, Inc.. There are 10,123 FDA adverse event reports linking TOPIRAMATE to DRUG INEFFECTIVE. This represents approximately 5.0% of all 203,737 adverse event reports for this drug.
TOPIRAMATE has an overall safety score of 85 out of 100. Patients taking TOPIRAMATE who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is moderately reported among TOPIRAMATE users, representing a notable but not dominant share of adverse events.
In addition to drug ineffective, the following adverse reactions have been reported for TOPIRAMATE:
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 10,123 FDA reports for TOPIRAMATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 5.0% of all adverse event reports for TOPIRAMATE, making it one of the most commonly reported side effect.
If you experience drug ineffective while taking TOPIRAMATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.